Park, K. (2016). Afatinib for patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer: Clinical implications of the LUX-Lung 7 study. Ann Transl Med.
Citação norma ChicagoPark, Keunchil. "Afatinib for Patients With Epidermal Growth Factor Receptor Mutation-positive Non-small Cell Lung Cancer: Clinical Implications of the LUX-Lung 7 Study." Ann Transl Med 2016.
Deismireacht MLAPark, Keunchil. "Afatinib for Patients With Epidermal Growth Factor Receptor Mutation-positive Non-small Cell Lung Cancer: Clinical Implications of the LUX-Lung 7 Study." Ann Transl Med 2016.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.